SHUKLA SANJAY (President and CEO) sold 2.4% of their position (3.75K shares) of ATYR PHARMA INC on the open market
Open‑market sale worth $3.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/4/2026ACC: 0001193125-26-038007
Officer· President and CEO
Since Feb 2019
-3.75K
Net shares
Net seller
$3.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10.38K acquired · 14.12K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10.38K
Price / share
—
Trade value
—
% of position
7.1%
2/3/2026
146.92K→157.30K
Common Stock
Direct
Shares
−3.75K
Price / share
$0.98
Trade value
$3.66K
% of position
2.4%
2/4/2026
157.30K→153.55K
Total
Net shares
+6.63K
Net value
-$3.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2026 | M · Option Exercise | +10.38K | — | — | 7.1% | 146.92K | 157.30K |
| Common Stock Direct | 2/4/2026 | S · Sale | −3.75K | $0.98 | $3.66K | 2.4% | 157.30K | 153.55K |
| Total | +6.63K | -$3.66K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
10.38K shares
Shares
−10.38K
Strike price
Held after
0.00
Exercisable
—
2/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock10.38K shares | 2/3/2026 | M · Option Exercise | −10.38K | — | 0.00 |